IRIDEX Corporation (IRIX)
USD 0.95
(-7.77%)
USD 0.95
(-7.77%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 51.86 Million USD | -8.96% |
| 2022 | 56.97 Million USD | 5.69% |
| 2021 | 53.9 Million USD | 48.3% |
| 2020 | 36.34 Million USD | -16.34% |
| 2019 | 43.44 Million USD | 1.99% |
| 2018 | 42.6 Million USD | 2.42% |
| 2017 | 41.59 Million USD | -9.89% |
| 2016 | 46.15 Million USD | 10.54% |
| 2015 | 41.75 Million USD | -2.47% |
| 2014 | 42.81 Million USD | 11.86% |
| 2013 | 38.27 Million USD | 13.04% |
| 2012 | 33.85 Million USD | 2.11% |
| 2011 | 33.15 Million USD | -24.11% |
| 2010 | 43.69 Million USD | 1.12% |
| 2009 | 43.21 Million USD | -10.95% |
| 2008 | 48.52 Million USD | -12.61% |
| 2007 | 55.53 Million USD | 54.67% |
| 2006 | 35.9 Million USD | -3.04% |
| 2005 | 37.02 Million USD | 12.86% |
| 2004 | 32.81 Million USD | 3.5% |
| 2003 | 31.69 Million USD | 3.48% |
| 2002 | 30.63 Million USD | 12.32% |
| 2001 | 27.27 Million USD | -18.43% |
| 2000 | 33.43 Million USD | 24.94% |
| 1999 | 26.76 Million USD | 13.4% |
| 1998 | 23.6 Million USD | 30.39% |
| 1997 | 18.1 Million USD | 45.97% |
| 1996 | 12.4 Million USD | 40.91% |
| 1995 | 8.8 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 11.76 Million USD | -5.59% |
| 2024 Q2 | 12.63 Million USD | 7.4% |
| 2023 Q3 | 12.85 Million USD | -0.04% |
| 2023 Q1 | 13.7 Million USD | -9.8% |
| 2023 FY | 51.86 Million USD | -8.96% |
| 2023 Q4 | 12.45 Million USD | -3.05% |
| 2023 Q2 | 12.85 Million USD | -6.21% |
| 2022 FY | 56.97 Million USD | 5.69% |
| 2022 Q4 | 15.19 Million USD | 3.83% |
| 2022 Q3 | 14.63 Million USD | 6.4% |
| 2022 Q1 | 13.38 Million USD | -12.24% |
| 2022 Q2 | 13.75 Million USD | 2.75% |
| 2021 Q4 | 15.25 Million USD | 15.0% |
| 2021 FY | 53.9 Million USD | 48.3% |
| 2021 Q1 | 11.95 Million USD | -2.8% |
| 2021 Q2 | 13.42 Million USD | 12.27% |
| 2021 Q3 | 13.26 Million USD | -1.21% |
| 2020 Q1 | 9.02 Million USD | -23.3% |
| 2020 Q2 | 6.21 Million USD | -31.06% |
| 2020 Q3 | 8.8 Million USD | 41.55% |
| 2020 Q4 | 12.3 Million USD | 39.77% |
| 2020 FY | 36.34 Million USD | -16.34% |
| 2019 Q2 | 10.42 Million USD | -1.6% |
| 2019 FY | 43.44 Million USD | 1.99% |
| 2019 Q4 | 11.76 Million USD | 10.3% |
| 2019 Q1 | 10.59 Million USD | -7.6% |
| 2019 Q3 | 10.66 Million USD | 2.28% |
| 2018 Q1 | 9.5 Million USD | -7.17% |
| 2018 Q2 | 10.3 Million USD | 8.36% |
| 2018 Q3 | 11.32 Million USD | 9.86% |
| 2018 Q4 | 11.46 Million USD | 1.3% |
| 2018 FY | 42.6 Million USD | 2.42% |
| 2017 Q1 | 10.48 Million USD | -16.34% |
| 2017 Q2 | 10 Million USD | -4.59% |
| 2017 Q4 | 10.24 Million USD | -5.72% |
| 2017 Q3 | 10.86 Million USD | 8.63% |
| 2017 FY | 41.59 Million USD | -9.89% |
| 2016 Q1 | 11.93 Million USD | -1.5% |
| 2016 Q2 | 11.9 Million USD | -0.19% |
| 2016 FY | 46.15 Million USD | 10.54% |
| 2016 Q4 | 12.53 Million USD | 28.0% |
| 2016 Q3 | 9.78 Million USD | -17.79% |
| 2015 FY | 41.75 Million USD | -2.47% |
| 2015 Q2 | 9.03 Million USD | -16.33% |
| 2015 Q1 | 10.79 Million USD | -8.34% |
| 2015 Q4 | 12.11 Million USD | 23.41% |
| 2015 Q3 | 9.81 Million USD | 8.66% |
| 2014 FY | 42.81 Million USD | 11.86% |
| 2014 Q1 | 10.32 Million USD | -2.54% |
| 2014 Q2 | 10.58 Million USD | 2.52% |
| 2014 Q3 | 10.11 Million USD | -4.45% |
| 2014 Q4 | 11.77 Million USD | 16.41% |
| 2013 Q4 | 10.59 Million USD | 11.25% |
| 2013 Q3 | 9.52 Million USD | 3.43% |
| 2013 Q2 | 9.21 Million USD | 3.03% |
| 2013 Q1 | 8.93 Million USD | -3.13% |
| 2013 FY | 38.27 Million USD | 13.04% |
| 2012 FY | 33.85 Million USD | 2.11% |
| 2012 Q4 | 9.22 Million USD | 17.09% |
| 2012 Q3 | 7.88 Million USD | -6.68% |
| 2012 Q2 | 8.44 Million USD | 1.69% |
| 2012 Q1 | 8.3 Million USD | 2232.87% |
| 2011 Q4 | 356 Thousand USD | -96.7% |
| 2011 Q1 | 11.21 Million USD | -8.31% |
| 2011 Q2 | 10.79 Million USD | -3.69% |
| 2011 FY | 33.15 Million USD | -24.11% |
| 2011 Q3 | 10.79 Million USD | -0.05% |
| 2010 FY | 43.69 Million USD | 1.12% |
| 2010 Q4 | 12.22 Million USD | 13.03% |
| 2010 Q2 | 9.89 Million USD | -8.07% |
| 2010 Q3 | 10.81 Million USD | 9.38% |
| 2010 Q1 | 10.75 Million USD | -6.96% |
| 2009 FY | 43.21 Million USD | -10.95% |
| 2009 Q4 | 11.56 Million USD | 11.18% |
| 2009 Q3 | 10.4 Million USD | -1.07% |
| 2009 Q1 | 10.73 Million USD | -11.6% |
| 2009 Q2 | 10.51 Million USD | -2.08% |
| 2008 Q2 | 12.92 Million USD | 12.62% |
| 2008 Q4 | 12.14 Million USD | 1.32% |
| 2008 Q3 | 11.98 Million USD | -7.24% |
| 2008 FY | 48.52 Million USD | -12.61% |
| 2008 Q1 | 11.47 Million USD | -18.87% |
| 2007 Q1 | 12.56 Million USD | 39.08% |
| 2007 FY | 55.53 Million USD | 54.67% |
| 2007 Q4 | 14.14 Million USD | 4.18% |
| 2007 Q3 | 13.57 Million USD | -10.98% |
| 2007 Q2 | 15.24 Million USD | 21.35% |
| 2006 FY | 35.9 Million USD | -3.04% |
| 2006 Q2 | 8.8 Million USD | -2.29% |
| 2006 Q3 | 9.22 Million USD | 4.75% |
| 2006 Q1 | 9.01 Million USD | -13.5% |
| 2006 Q4 | 9.03 Million USD | -2.03% |
| 2005 Q1 | 8.14 Million USD | -10.8% |
| 2005 Q2 | 9.38 Million USD | 15.25% |
| 2005 Q3 | 9.08 Million USD | -3.26% |
| 2005 Q4 | 10.41 Million USD | 14.7% |
| 2005 FY | 37.02 Million USD | 12.86% |
| 2004 FY | 32.81 Million USD | 3.5% |
| 2004 Q4 | 9.13 Million USD | 11.65% |
| 2004 Q3 | 8.17 Million USD | 0.85% |
| 2004 Q2 | 8.1 Million USD | 9.7% |
| 2004 Q1 | 7.39 Million USD | -15.72% |
| 2003 Q1 | 7.22 Million USD | -24.1% |
| 2003 Q3 | 8.26 Million USD | 11.19% |
| 2003 Q4 | 8.77 Million USD | 6.1% |
| 2003 Q2 | 7.43 Million USD | 2.89% |
| 2003 FY | 31.69 Million USD | 3.48% |
| 2002 Q2 | 7.43 Million USD | 6.75% |
| 2002 Q1 | 6.96 Million USD | -9.59% |
| 2002 FY | 30.63 Million USD | 12.32% |
| 2002 Q4 | 9.52 Million USD | 41.74% |
| 2002 Q3 | 6.71 Million USD | -9.63% |
| 2001 Q4 | 7.7 Million USD | 14.1% |
| 2001 Q3 | 6.75 Million USD | -4.77% |
| 2001 Q2 | 7.08 Million USD | 23.59% |
| 2001 Q1 | 5.73 Million USD | -27.97% |
| 2001 FY | 27.27 Million USD | -18.43% |
| 2000 FY | 33.43 Million USD | 24.94% |
| 2000 Q4 | 7.96 Million USD | -6.31% |
| 2000 Q3 | 8.49 Million USD | -3.27% |
| 2000 Q2 | 8.78 Million USD | 7.24% |
| 2000 Q1 | 8.19 Million USD | -0.85% |
| 1999 Q1 | 5.7 Million USD | -12.31% |
| 1999 FY | 26.76 Million USD | 13.4% |
| 1999 Q4 | 8.26 Million USD | 31.14% |
| 1999 Q3 | 6.3 Million USD | -3.08% |
| 1999 Q2 | 6.5 Million USD | 14.04% |
| 1998 FY | 23.6 Million USD | 30.39% |
| 1998 Q4 | 6.5 Million USD | 25.0% |
| 1998 Q3 | 5.2 Million USD | -13.33% |
| 1998 Q2 | 6 Million USD | 1.69% |
| 1998 Q1 | 5.9 Million USD | 1.72% |
| 1997 Q4 | 5.8 Million USD | 26.09% |
| 1997 FY | 18.1 Million USD | 45.97% |
| 1997 Q2 | 4.4 Million USD | 33.33% |
| 1997 Q1 | 3.3 Million USD | -32.65% |
| 1997 Q3 | 4.6 Million USD | 4.55% |
| 1996 FY | 12.4 Million USD | 40.91% |
| 1996 Q1 | 2.4 Million USD | 4.35% |
| 1996 Q2 | 2.5 Million USD | 4.17% |
| 1996 Q3 | 2.6 Million USD | 4.0% |
| 1996 Q4 | 4.9 Million USD | 88.46% |
| 1995 FY | 8.8 Million USD | 0.0% |
| 1995 Q3 | 2.1 Million USD | -4.55% |
| 1995 Q4 | 2.3 Million USD | 9.52% |
| 1995 Q1 | 2.1 Million USD | 0.0% |
| 1995 Q2 | 2.2 Million USD | 4.76% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | -624.023% |
| Cerus Corporation | 156.36 Million USD | 66.829% |
| OrthoPediatrics Corp. | 148.73 Million USD | 65.126% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -5254.463% |
| Talis Biomedical Corporation | 412 Thousand USD | -12489.563% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -275.835% |
| Inogen, Inc. | 315.66 Million USD | 83.568% |
| Spectral AI, Inc. | 18.05 Million USD | -187.267% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -423.665% |
| CVRx, Inc. | 39.29 Million USD | -31.999% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -7954.193% |
| Orthofix Medical Inc. | 746.64 Million USD | 93.053% |
| Venus Concept Inc. | 76.35 Million USD | 32.068% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -330.127% |
| Bioventus Inc. | 512.34 Million USD | 89.876% |
| BrainsWay Ltd. | 31.78 Million USD | -63.187% |
| Envoy Medical, Inc. | 316 Thousand USD | -16314.241% |
| electroCore, Inc. | 16.03 Million USD | -223.575% |
| IceCure Medical Ltd | 3.22 Million USD | -1506.349% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -2036.285% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -14110.724% |
| MaxCyte, Inc. | 41.28 Million USD | -25.627% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -2556.623% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -46735.157% |
| PAVmed Inc | 2.45 Million USD | -2015.375% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -130.334% |
| RxSight, Inc. | 89.07 Million USD | 41.771% |
| Sight Sciences, Inc. | 81.05 Million USD | 36.008% |
| SI-BONE, Inc. | 138.88 Million USD | 62.654% |
| TELA Bio, Inc. | 58.45 Million USD | 11.264% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -180.206% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 72.28% |
| LivaNova PLC | 1.15 Billion USD | 95.504% |
| 908 Devices Inc. | 50.22 Million USD | -3.265% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 89.245% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -67223.867% |
| NeuroPace, Inc. | 65.42 Million USD | 20.715% |
| LENSAR, Inc. | 42.16 Million USD | -23.017% |
| Apyx Medical Corporation | 52.34 Million USD | 0.917% |
| Cutera, Inc. | 212.36 Million USD | 75.576% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -55.492% |
| BioSig Technologies, Inc. | 18 Thousand USD | -288061.111% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 68.878% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -116.527% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 96.635% |
| Axonics, Inc. | 366.37 Million USD | 85.843% |
| Outset Medical, Inc. | 130.37 Million USD | 60.216% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 61.915% |
| IRadimed Corporation | 65.56 Million USD | 20.886% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -4310.629% |
| INVO Bioscience, Inc. | 3.02 Million USD | -1617.19% |
| Telesis Bio, Inc. | 27.5 Million USD | -88.553% |
| Viemed Healthcare, Inc. | 183 Million USD | 71.658% |
| Varex Imaging Corporation | 811 Million USD | 93.604% |
| Quipt Home Medical Corp. | 221.74 Million USD | 76.608% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 24.472% |
| Dynatronics Corporation | 32.53 Million USD | -59.43% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -497.707% |
| Semler Scientific, Inc. | 68.18 Million USD | 23.928% |
| InMode Ltd. | 492.04 Million USD | 89.459% |
| Bruker Corporation | 2.96 Billion USD | 98.25% |
| Cytosorbents Corporation | 36.34 Million USD | -42.696% |
| DexCom, Inc. | 3.62 Billion USD | 98.568% |
| Align Technology, Inc. | 3.86 Billion USD | 98.657% |
| Viveve Medical, Inc. | 6.42 Million USD | -707.174% |
| ZimVie Inc. | 457.43 Million USD | 88.661% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 73.127% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -46735.157% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 93.063% |
| Profound Medical Corp. | 7.33 Million USD | -607.528% |
| Insulet Corporation | 1.69 Billion USD | 96.944% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 58.86% |
| iCAD, Inc. | 17.31 Million USD | -199.509% |
| Nuwellis, Inc. | 8.86 Million USD | -485.165% |
| Biotricity, Inc. | 12.06 Million USD | -329.972% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 89.472% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -735.923% |
| PAVmed Inc. | 2.45 Million USD | -2015.375% |
| BIOLASE, Inc. | 49.16 Million USD | -5.502% |
| Beyond Air, Inc. | 1.15 Million USD | -4375.324% |
| FONAR Corporation | 102.88 Million USD | 49.585% |
| AxoGen, Inc. | 159.01 Million USD | 67.38% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 81.099% |
| Inari Medical, Inc. | 493.63 Million USD | 89.492% |
| UFP Technologies, Inc. | 400.07 Million USD | 87.035% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -278765.591% |
| Tenon Medical, Inc. | 2.92 Million USD | -1671.482% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -661.431% |
| AdaptHealth Corp. | 3.2 Billion USD | 98.379% |
| Sintx Technologies, Inc. | 2.62 Million USD | -1874.458% |
| NanoVibronix, Inc. | 2.28 Million USD | -2171.967% |
| Quanterix Corporation | 122.36 Million USD | 57.612% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -112.534% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 74.133% |
| TransMedics Group, Inc. | 241.62 Million USD | 78.533% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -274.397% |
| NeuroMetrix, Inc. | 5.9 Million USD | -778.923% |
| Hyperfine, Inc. | 11.03 Million USD | -370.169% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 68.593% |
| Biomerica, Inc. | 5.41 Million USD | -857.876% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -2.587% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 70.718% |